XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Equity
$ in Thousands
USD ($)
shares
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Share capital
USD ($)
shares
Share capital
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
shares
Contributed surplus
USD ($)
Contributed surplus
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Accumulated deficit
USD ($)
Accumulated deficit
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Foreign currency reserve
USD ($)
Foreign currency reserve
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
DSUs
USD ($)
DSUs
Share capital
USD ($)
shares
DSUs
Contributed surplus
USD ($)
RSUs
USD ($)
shares
RSUs
Share capital
USD ($)
shares
RSUs
Contributed surplus
USD ($)
Beginning balance (in shares) at Dec. 31, 2021 | shares     297,700,295                          
Beginning balance at Dec. 31, 2021 $ 1,327,017   $ 2,416,256   $ 297,819   $ (1,388,779)   $ 1,721              
Changes in Stock Holders Equity [Roll Forward]                                
Net loss (173,494) [1]           (173,494)                  
Deferred share consideration related to acquisition (in shares) | shares     112,451                          
Deferred share consideration related to acquisition $ (20)   $ 1,762   (1,782)                      
Redeemed/exercised (in shares) | shares 304,635   304,635                 58,990   217,832 217,832  
Redeemed/exercised $ 916   $ 1,349   (433)           $ (753) $ 244 $ (997) $ (2,466) $ 785 $ (3,251)
Share-based compensation 9,408       9,408           753     $ 2,466    
Other comprehensive income (loss):                                
Defined benefit plan actuarial gain 1,514 [1]           1,514                  
Foreign currency translation for foreign operations $ (3,211) [1]               (3,211)              
Ending balance (in shares) at Dec. 31, 2022 | shares 298,394,203     298,394,203                        
Ending balance at Dec. 31, 2022 $ 1,158,911 $ 1,158,911   $ 2,420,396   $ 300,764   $ (1,560,759)   $ (1,490)            
Changes in Stock Holders Equity [Roll Forward]                                
Net loss (177,716)           (177,716)                  
Deferred share consideration related to acquisition (in shares) | shares     224,902                          
Deferred share consideration related to acquisition $ (15)   $ 3,053   (3,068)                      
Redeemed/exercised (in shares) | shares 152,120   152,120                 31,736   132,745 132,745  
Redeemed/exercised $ 335   $ 504   (169)           (171) $ 194 $ (365) $ (585) $ 1,494 $ (2,079)
Share-based compensation 10,959       10,959           $ 171     $ 585    
Other comprehensive income (loss):                                
Defined benefit plan actuarial gain 970           970                  
Foreign currency translation for foreign operations $ (1,472)               (1,472)              
Ending balance (in shares) at Dec. 31, 2023 | shares 298,935,706   298,935,706                          
Ending balance at Dec. 31, 2023 $ 991,216   $ 2,425,641   $ 306,042   $ (1,737,505)   $ (2,962)              
[1] Comparative information has been restated due to a discontinued operation (note 7).